Produttore cinese di polveri di steroidi anabolizzanti
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнська

Peptidi farmaceutici

» Peptidi » Peptidi farmaceutici

  • Specifiche
  • Descrizione del prodotto
  • Utilizzo del prodotto
  • COA
Nome del prodotto Triptorelin Acetate
CAS NO. 140194-24-7
MF C64H82N18O13
MW 1311.45
EINECS NO. N / A
Purezza 99%
Aspetto White freeze dried powder
Magazzinaggio Store at -20°C

Triptorelin is a gonadotropin-releasing hormone agonist used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone and follicle stimulating hormone. Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions, and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl and Diphereline and Gonapeptyl.

Triptorelin,a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) e l'ormone follicolo-stimolante (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. It is also used as therapy in cases of gender dysphoria.

Triptorelin is a GNRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo.

1. Triptorelin can improve the pregnancy rate by 12% A 15% in ewes6 and downregulate ovarian GNRHR-I expression of female rats, especially in late-growing follicles.

2. Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins.

3. Triptorelin may be used in the treatment of hormone-responsive cancers such as breast cancer or prostate cancer, precocious puberty, estrogen-dependent conditions, and assisted reproduction.

Singola impurità (HPLC): 1.0%massimo
Amino Acid Composition: ±10% of theoretical
Peptide Content (N%): ≥80,0%
Contenuto d'acqua(Karl Fisher): ≤6.0%
Triptorelin Acetate Acetate Content (HPIC): ≤15.0%
Triptorelin Acetate MS(ESI): Consistent
Triptorelin Acetate Mass Balance: 95.0~105,0%
Triptorelin Acetate Specific Rotation (20/D): -65.0~-75.0°(c=0.5 1%HAc)

Modulo di richiesta ( ti risponderemo il prima possibile )

Nome:
*
E-mail:
*
Messaggio:

Verifica:
4 + 5 = ?

Forse piace anche a te

  • Il nostro vantaggio

    Buon prezzo

    Alta qualità

    Consegna veloce

    Spedizione sicura

    Eccellente servizio post-vendita

  • Magazzino locale

    Magazzino UE

    Magazzino del Regno Unito

    Magazzino degli Stati Uniti

    Magazzino canadese

    Magazzino australiano

  • Metodo di pagamento

    PayPal

    Bitcoin

    Bonifico bancario

    Grammo dei soldi

    Unione occidentale

  • Contattaci

    E-mail: jacob@steroid-peptide.com

    Whatsapp: +8615636286252

    Telefono: 0086-15636286252

    Sito web: www.steroid-peptide.com

    Accolga favorevolmente la vostra indagine